Day One Biopharmaceuticals (DAWN) PT Raised to $38 at Jones Trading on OJEMDA approval, sees $900M peak sales
Tweet Send to a Friend
(Updated - April 24, 2024 10:02 AM EDT)
Jones Trading analyst Soumit Roy raised the price target on Day ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Jones Trading analyst Soumit Roy raised the price target on Day ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
